Yasemi̇n Gökdemi̇r
Biographic Data
| ID | 7057923 |
|---|---|
| NAME | Yasemi̇n Gökdemi̇r |
| GIVEN NAMES | Yasemi̇n |
| FAMILY NAME | Gökdemi̇r |
| SIGNATURE | GÖKDEMİR Y |
| AFFILIATIONS | Marmara University |
| ORCID | 0000-0002-0853-7932 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Personalized Management and Timing of Thymectomy in Juvenile Myasthenia Gravis
Introduction: Juvenile myasthenia gravis (JMG) is a rare autoimmune disorder with a variable clinical course and limited pediatric-specific treatment guidelines. Objective clinical scales, such as the Quantitative Myasthenia Gravis (QMG) Score and the Pediatric Myasthenia Gravis Quality of Life 15 (PM-QOL15), may support individualized management, but their role in routine practice remains underexplored. Methods: We retrospectively reviewed 10 se…
Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy
To accurately assess respiratory muscle strength, supine FVC should be combined with upright FVC, MIP, MEP, and SNIP measurements. It is crucial to regularly screen patients for nutrition, as this can significantly affect respiratory muscle function during pulmonology follow-up
No prominent works on this page.
Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy
To accurately assess respiratory muscle strength, supine FVC should be combined with upright FVC, MIP, MEP, and SNIP measurements. It is crucial to regularly screen patients for nutrition, as this can significantly affect respiratory muscle function during pulmonology follow-up
Personalized Management and Timing of Thymectomy in Juvenile Myasthenia Gravis
Introduction: Juvenile myasthenia gravis (JMG) is a rare autoimmune disorder with a variable clinical course and limited pediatric-specific treatment guidelines. Objective clinical scales, such as the Quantitative Myasthenia Gravis (QMG) Score and the Pediatric Myasthenia Gravis Quality of Life 15 (PM-QOL15), may support individualized management, but their role in routine practice remains underexplored. Methods: We retrospectively reviewed 10 se…
Adverse effect (1 work) · Ambulatory (1 work) · Asthma (1 work) · Azathioprine (1 work) · Cardiology (1 work) · Chronic Obstructive Pulmonary Disease (COPD) Research (1 work) · Diffusing capacity (1 work) · Duchenne muscular dystrophy (1 work) · Internal Medicine (1 work) · Lung (1 work)